Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning prediction of increased healthcare utilization in colectomy for inflammatory bowel disease.

International journal of colorectal disease·2026
Same author

Technique and outcomes of posterior layer supplementation in retromuscular ventral hernia repair.

Surgical endoscopy·2026
Same author

Technical Description of a Non-Assisted Intracorporeal Pringle Maneuver for Robotic Liver Resection.

Journal of visualized experiments : JoVE·2026
Same author

The Differential Impact of Neoadjuvant Therapies on the Tumor Microenvironment, Peripheral Biomarkers, and Survival in Pancreatic Cancer: A Retrospective Cohort Study.

Cancers·2026
Same author

Implications of Heterotypic Cell Fusion in Cancer.

Advances in experimental medicine and biology·2026
Same author

Addressing pancreatic cancer disparities in Oregon's Native American population via tribally responsive research systems with the confederated tribes of warm springs.

Cancer causes & control : CCC·2026

Related Experiment Video

Updated: Jun 14, 2025

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.4K

Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in

Ranish K Patel1, Gustavo Salgado-Garza1, Thomas L Sutton1

  • 1Oregon Health & Science University (OHSU), Department of Surgery, Portland, OR 97239, USA.

HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|September 6, 2024
PubMed
Summary
This summary is machine-generated.

Rapid recurrence of pancreatic cancer (PDAc) remains high. Surgical site infections and nodal positivity increase risk, while adjuvant therapy lowers it, highlighting a need for targeted prevention strategies.

More Related Videos

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.5K
Modified Single-Loop Reconstruction for Pancreaticoduodenectomy
00:13

Modified Single-Loop Reconstruction for Pancreaticoduodenectomy

Published on: September 28, 2019

7.4K

Related Experiment Videos

Last Updated: Jun 14, 2025

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.4K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

10.5K
Modified Single-Loop Reconstruction for Pancreaticoduodenectomy
00:13

Modified Single-Loop Reconstruction for Pancreaticoduodenectomy

Published on: September 28, 2019

7.4K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Cancer Epidemiology

Background:

  • Pancreatic ductal adenocarcinoma (PDAc) is a highly lethal cancer.
  • High rates of rapid recurrence (rrPDAc) after surgery contribute to poor outcomes.
  • Understanding predictors of rrPDAc is crucial for improving patient survival.

Purpose of the Study:

  • To characterize recurrence rates over time in PDAc patients.
  • To identify factors associated with rapid recurrence (rrPDAc) following curative-intent resection.

Main Methods:

  • Utilized a multi-institutional cancer registry and the National Surgical Quality Improvement Program database.
  • Analyzed data from 924 patients who underwent PDAc resection between 1996 and 2020.
  • Defined rrPDAc as recurrence within 6 months post-surgery.

Main Results:

  • 26% of patients experienced rrPDAc, with a median annual incidence of 25.3%.
  • rrPDAc significantly reduced median survival (10.3 months) compared to non-rapid recurrence (25.2 months) and no recurrence (56.1 months).
  • Surgical site infections (SSI) and nodal positivity were linked to increased rrPDAc risk; adjuvant therapy was associated with decreased risk.

Conclusions:

  • The incidence of rrPDAc has not changed despite advances in treatment.
  • Preventing SSIs and managing nodal status are key to reducing rrPDAc.
  • Adjuvant chemotherapy shows promise in lowering the risk of rapid recurrence, potentially improving survival outcomes.